GB9810180D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
GB9810180D0
GB9810180D0 GBGB9810180.1A GB9810180A GB9810180D0 GB 9810180 D0 GB9810180 D0 GB 9810180D0 GB 9810180 A GB9810180 A GB 9810180A GB 9810180 D0 GB9810180 D0 GB 9810180D0
Authority
GB
United Kingdom
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810180.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9810180.1A priority Critical patent/GB9810180D0/en
Publication of GB9810180D0 publication Critical patent/GB9810180D0/en
Priority to PL99344872A priority patent/PL344872A1/xx
Priority to AU39410/99A priority patent/AU3941099A/en
Priority to EP99922303A priority patent/EP1077685A2/en
Priority to PCT/GB1999/001522 priority patent/WO1999058116A2/en
Priority to EA200001173A priority patent/EA200001173A1/ru
Priority to SK1697-2000A priority patent/SK16972000A3/sk
Priority to CN99808548A priority patent/CN1309557A/zh
Priority to CA002331849A priority patent/CA2331849A1/en
Priority to APAP/P/2000/001985A priority patent/AP2000001985A0/en
Priority to TR2000/03351T priority patent/TR200003351T2/xx
Priority to HU0101931A priority patent/HUP0101931A3/hu
Priority to KR1020007012660A priority patent/KR20010043545A/ko
Priority to JP2000547967A priority patent/JP2002514593A/ja
Priority to BR9910402-4A priority patent/BR9910402A/pt
Priority to IDW20002329A priority patent/ID27018A/id
Priority to IL13959699A priority patent/IL139596A0/xx
Priority to ZA200006465A priority patent/ZA200006465B/en
Priority to NO20005681A priority patent/NO20005681L/no
Priority to BG105011A priority patent/BG105011A/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9810180.1A 1998-05-13 1998-05-13 Novel formulation Ceased GB9810180D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
IL13959699A IL139596A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
CA002331849A CA2331849A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
TR2000/03351T TR200003351T2 (tr) 1998-05-13 1999-05-13 Paroksetin içeren yeni formülasyon
EP99922303A EP1077685A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
EA200001173A EA200001173A1 (ru) 1998-05-13 1999-05-13 Новый состав, содержащий пароксетин
SK1697-2000A SK16972000A3 (sk) 1998-05-13 1999-05-13 Hydrochlorid paroxetínu vo forme inej než hemihydrát formulovaný do kapsúl, spôsob výroby kapsúl s obsahom hydrochloridu paroxetínu a súprava zahrnujúca takého kapsuly
CN99808548A CN1309557A (zh) 1998-05-13 1999-05-13 含有帕罗西汀的新制剂
PL99344872A PL344872A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
APAP/P/2000/001985A AP2000001985A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.
AU39410/99A AU3941099A (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
HU0101931A HUP0101931A3 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
KR1020007012660A KR20010043545A (ko) 1998-05-13 1999-05-13 파록세틴을 함유하는 신규 제형
JP2000547967A JP2002514593A (ja) 1998-05-13 1999-05-13 新規なパロキセチンを含む処方
BR9910402-4A BR9910402A (pt) 1998-05-13 1999-05-13 Nova formulação contendo paroxetina
IDW20002329A ID27018A (id) 1998-05-13 1999-05-13 Formulasi baru yang mengandung paroksetin
ZA200006465A ZA200006465B (en) 1998-05-13 2000-11-09 Novel formulation containing paroxetine.
NO20005681A NO20005681L (no) 1998-05-13 2000-11-10 Nye formuleringer som inneholder paroxetin
BG105011A BG105011A (en) 1998-05-13 2000-11-30 Composition containing paroxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation

Publications (1)

Publication Number Publication Date
GB9810180D0 true GB9810180D0 (en) 1998-07-08

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810180.1A Ceased GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation

Country Status (20)

Country Link
EP (1) EP1077685A2 (hu)
JP (1) JP2002514593A (hu)
KR (1) KR20010043545A (hu)
CN (1) CN1309557A (hu)
AP (1) AP2000001985A0 (hu)
AU (1) AU3941099A (hu)
BG (1) BG105011A (hu)
BR (1) BR9910402A (hu)
CA (1) CA2331849A1 (hu)
EA (1) EA200001173A1 (hu)
GB (1) GB9810180D0 (hu)
HU (1) HUP0101931A3 (hu)
ID (1) ID27018A (hu)
IL (1) IL139596A0 (hu)
NO (1) NO20005681L (hu)
PL (1) PL344872A1 (hu)
SK (1) SK16972000A3 (hu)
TR (1) TR200003351T2 (hu)
WO (1) WO1999058116A2 (hu)
ZA (1) ZA200006465B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
PL344872A1 (en) 2001-11-19
EP1077685A2 (en) 2001-02-28
KR20010043545A (ko) 2001-05-25
BR9910402A (pt) 2001-01-09
NO20005681L (no) 2000-12-01
WO1999058116A2 (en) 1999-11-18
CN1309557A (zh) 2001-08-22
AU3941099A (en) 1999-11-29
HUP0101931A3 (en) 2002-10-28
BG105011A (en) 2001-07-31
AP2000001985A0 (en) 2000-12-31
HUP0101931A2 (hu) 2002-04-29
IL139596A0 (en) 2002-02-10
WO1999058116A3 (en) 2000-02-17
TR200003351T2 (tr) 2001-03-21
NO20005681D0 (no) 2000-11-10
EA200001173A1 (ru) 2001-04-23
SK16972000A3 (sk) 2001-06-11
ID27018A (id) 2001-02-22
JP2002514593A (ja) 2002-05-21
ZA200006465B (en) 2001-11-09
CA2331849A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
PL343021A1 (en) Formulations
ZA9811461B (en) New formulation
GB9809058D0 (en) Composition
PL342600A1 (en) Composition
HK1026429A1 (en) New formulation
GB9812119D0 (en) Composition
EP1068213A4 (en) SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
GB9806788D0 (en) Composition
GB9724544D0 (en) Novel Formulation
GB9827894D0 (en) Composition
GB9806793D0 (en) Composition
GB9806312D0 (en) Novel formulations
GB9725061D0 (en) Revitalisation formulation
GB9810180D0 (en) Novel formulation
GB9813714D0 (en) Composition
GB9706957D0 (en) Formulation
GB9903310D0 (en) Composition
GB9815001D0 (en) Formulations
GB9815002D0 (en) Formulations
GB9804041D0 (en) Composition
GB9810181D0 (en) Novel formulations
AU1649700A (en) Novel formulation
GB9806791D0 (en) Composition
GB9818905D0 (en) Novel formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)